surpass-cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What SURPASS-CVOT: Tirzepatide better than dulagluti...

Tirzepatide: a Novel, once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes

Between them, tirzepatide is the more effective option for its dual mechanisms of action

Empower Pharmacy , Olympia Pharmacy , and similar large compounders primarily accept standard payment methods

This molecule forms when a naturally occurring peptide known as GHK binds with a copper ion, creating a complex that has been widely studied in relation to skin biology and tissue signaling

It is being explored for immune modulation, chronic infections, viral support, immune resilience, inflammation balance, and complex chronic illness